Presence of Iranian tissue product at the 65th International Congress of the Iranian Dental Association (EXCIDA 2026)

Iranian tissue product participated in, the 65th International, Congress of the Iranian Dental Association (EXCIDA 2026) to introduce its capabilities, products and innovative solutions, in regenerative medicine and human, allografts.

This event is one of the most important scientific and professional gatherings for the Iranian dental community, bringing together dentists, oral and maxillofacial surgeons, researchers, knowledge-based companies, and professionals working in the field of medical equipment and products. The 65th edition of the EXCIDA Congress was held from August 3 to 6, 1405, at the Iran Mall Convention Center.

The participation of Iranian tissue product in this congress provided an opportunity to engage directly with the dental professional community, introduce products related to tissue and bone regeneration, and exchange insights on the needs and challenges facing modern dental treatment.

Presence of the CEO of Iranian tissue product at EXCIDA

EXCIDA: Where Knowledge, Technology, and Treatment Converge

Specialized dental congresses are not merely venues for presenting the latest scientific advancements; they also serve as platforms for fostering connections among specialists, researchers, manufacturers, and providers of innovative treatment solutions.

As one of the major events in Iran’s dental community, the EXCIDA Congress provides an opportunity to explore the latest technologies, products, and innovative approaches in dentistry and related surgical procedures.

Iranian tissue product also participated in EXCIDA 2026d to introduce some of its capabilities in the production and development of human tissue products and bioimplants.

Iranian Tissue Product; Advancing Regenerative Medicine Solutions

Iranian tissue product was founded in 2011 by a group of faculty members and staff of Tehran University of Medical Sciences and began its activities in the production and development of human tissue products.

Today, Iranian tissue product operates as a knowledge-based company specializing in human allografts and bio-implants. Its products are used across various medical fields, including orthopedics, dentistry and oral and maxillofacial surgery, otolaryngology, reconstructive surgery, as well as cardiovascular surgery.

A focus on specialized expertise, the development of indigenous technologies, and adherence to quality standards are among the core priorities of Iranian tissue product. The company has stated that its products and processes are developed in accordance with the ISO 13485:2016 standard and protocols associated with the AATB.

is approach is part of the company’s efforts to develop innovative solutions in regenerative medicine and address the specialized needs of physicians and healthcare centers.

The CEO, Technical Manager, Sales Manager, and Production Manager at the Iranian tissue product booth during the EXCIDA Congress

Introduction of products for dentistry and oral and maxillofacial surgery

One of the key areas of activity for Iranian tissue product is dentistry and oral and maxillofacial surgery.

In this field, the use of tissue products can be considered in certain treatment and tissue regeneration procedures. Depending on the type of tissue and its intended application, allograft products can be made available to specialists for use based on the patient’s condition and the physician’s diagnosis.

The Iranian tissue product portfolio includes various groups of tissue products, including bone products, dermal products, cartilage and septum products, fascia lata, and combination products.

Introducing these products at events such as EXCIDA provides an opportunity for direct dialogue with specialists and enables physicians to become familiar with the products’ features and applications.

Participation in EXCIDA 1405: An Opportunity to Connect with the Dental Community

One of the key objectives of Iranian tissue product’s participation in the EXCIDA 1405 Congress was to establish direct and professional connections with specialists in dentistry and oral and maxillofacial surgery.

Specialized events such as EXCIDA provide companies with an opportunity to gain firsthand insight into the perspectives and needs of the medical community. This two-way engagement, in addition to introducing products, can also help identify new opportunities for the development of products and services.

For a company operating in the field of regenerative medicine, engaging with physicians is not merely a commercial activity; it is an integral part of understanding the real needs of the healthcare sector and moving toward the development of more practical and effective solutions.

From this perspective, participation in the EXCIDA Congress can be regarded as part of Iranian tissue product’s ongoing efforts to maintain engagement with the country’s scientific and professional community.

Regenerative Medicine and the Future of Healthcare

Regenerative medicine is one of the important and rapidly developing fields in medical science, aiming to harness knowledge and technology to help repair, regenerate, and replace damaged tissues.

Human allografts are an important part of this field and can be used in a wide range of medical applications.

The development of technologies related to tissue processing, quality control, sterilization, and the preparation of tissue products plays an important role in enhancing the usability of these products in clinical settings.

Iranian tissue product focuses on the production and development of various human allografts and bio-implants, seeking to address some of the specialized needs of the regenerative medicine sector through technological development and domestic manufacturing. The company currently offers more than 20 specialized products and has a network of healthcare centers and sales representatives across the country.

Doctors and Specialists Visiting the Iranian Tissue Product Booth at the EXCIDA Congress

Why Is the Participation of Knowledge-Based Companies in Specialized Congresses Important?

The participation of knowledge-based companies in medical congresses provides an opportunity to foster closer connections between industry and the scientific community.

On the one hand, physicians and specialists can become familiar with new technologies and products, while on the other hand, companies can receive direct feedback from healthcare professionals.

This engagement can be valuable on several levels:

Understanding the Real Needs of Physicians and Healthcare Centers

Introducing New Products and Technologies

Receiving Expert Feedback on Products

Building Connections Between Industry and the Scientific Community

Identifying Opportunities for Collaboration and Development

Increasing Awareness of Domestic Manufacturing Capabilities

Helping Develop Solutions Tailored to Healthcare Needs

Iranian tissue product follows the same approach in its participation in specialized congresses and has previously taken part in professional events related to dentistry, implantology, and oral and maxillofacial surgery.

A Look at the Road Ahead for Iranian Tissue Product

Participation in the 65th International Congress of the Iranian Dental Association was more than an exhibition presence for Iranian tissue product. It was part of the companys ongoing engagement with the medical community and its efforts to showcase domestic manufacturing and technological capabilities.

Developing new products, enhancing quality, leveraging the latest knowledge, and expanding collaboration with specialists are among the pathways that can contribute to the advancement of regenerative medicine in the country.

Drawing on years of experience, specialized expertise, and domestic manufacturing infrastructure, Iranian tissue product continues its activities in the production and development of tissue products.

The company currently operates across various medical fields, including dentistry and oral and maxillofacial surgery, orthopedics and neurology, otolaryngology, reconstructive surgery, and cardiovascular surgery.

Summary

Iranian tissue product’s participation in the EXCIDA 1405 Congress provided an opportunity to showcase the company’s capabilities in allografts and regenerative medicine, as well as to establish direct connections with dentists and oral and maxillofacial surgeons.

The 65th International Congress of the Iranian Dental Association was held at Iran Mall from August 25 to 28, 2026, bringing together a broad segment of the country’s dental professional community.

For us, participating in such events is an opportunity to listen to specialists, better understand the needs of the healthcare sector, and continue developing products that can support regenerative medicine and improve the quality of care.

Iranian Tissue Product: Advancing Technology for the Future of Regenerative Medicine

For more information about the company’s products and areas of activity, you can refer to the Iranian Tissue Product catalogs.